| 证券代码：603585 | 证券简称：苏利股份 | 公告编号：2023-056 | | --- | --- | --- | | 转债代码：113640 | 转债简称：苏利转债 | | 江苏苏利精细化工股份有限公司 关于会计政策变更的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重 大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： （二）审议程序 2023 年 8 月 28 日，公司第四届董事会第十三次会议审议通过了《关于会计政策变 更的议案》，本议案无需提交股东大会审议。 二、本次会计政策变更的具体情况 （一）变更日期 公司将按照《企业会计准则解释第 16 号》的规定选择于 2023 年 1 月 1 日起执行。 本次会计政策变更是根据中华人民共和国财政部（以下简称"财政部"）会计司发 布的最新企业会计准则及相关通知的要求进行的相应变更，无需提交股东大会审议，修 订后的会计政策符合财政部、中国证监会和上海证券交易所等相关规定，能够客观、公 允地反映江苏苏利精细化工股份有限公司（以下简称"公司"）的财务状况和经营成果， 不会对公司当期损益、财务状况及 ...

| 证券代码：603585 | 证券简称：苏利股份 | 公告编号：2023-055 | | --- | --- | --- | | 转债代码：113640 | 转债简称：苏利转债 | | 江苏苏利精细化工股份有限公司 2023 年半年度主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据上海证券交易所《上市公司行业信息披露指引第十八号-化工》的要求， 江苏苏利精细化工股份有限公司（以下简称"公司"）现将 2023 年半年度主要 经营数据披露如下： 一、主要产品的产量、销量及收入实现情况 | 主要产品 | 产量 | 销量 | 营业收入 | | --- | --- | --- | --- | | | （吨） | （吨） | （万元） | | 农药及农药中间体 | 12,080.51 | 11,497.27 | 62,465.89 | | 阻燃剂及阻燃剂中 间体 | 5,381.85 | 6,033.09 | 25,049.96 | 二、主要产品的价格变动情况（不含税） | 主要产品 | 平均售价 | 上年同 ...

| 证券代码：603585 | 证券简称：苏利股份 公告编号：2023-031 | | --- | --- | | 转债代码：113640 | 转债简称：苏利转债 | 江苏苏利精细化工股份有限公司 关于召开 2022 年度暨 2023 年第一季度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 重要内容提示： 会议召开时间：2023 年 6 月 1 日(星期四)下午 15:00-16:30 本次投资者说明会以视频录制及网络文字互动的形式召开，公司将针对 2022 年年度及 2023 年第一季度的经营成果及财务指标的具体情况与投资者进行 会议召开地点：上海证券交易所上证路演中心(网址：http://roadshow.ssein fo.com/) 会议召开方式：视频录制及网络文字互动 互动交流和沟通，在信息披露允许的范围内就投资者普遍关注的问题进行回答。 二、 说明会召开的时间、地点 投资者可于 2023 年 5 月 30 日（星期二）16:00 前登录上证路演中心网站首页 点击"提问预征集"栏目或通过公司邮 ...

Financial Performance - The company's operating revenue for Q1 2023 was ¥552,072,654.56, representing a decrease of 30.53% compared to the same period last year[4]. - The net profit attributable to shareholders was ¥22,139,452.33, down 77.45% year-on-year[4]. - The net profit after deducting non-recurring gains and losses was ¥22,179,166.14, a decrease of 77.13% compared to the previous year[5]. - Basic earnings per share were ¥0.12, down 78.18% compared to the same period last year[5]. - Net profit for Q1 2023 was CNY 19.51 million, a decline of 84.4% from CNY 125.28 million in Q1 2022[20]. - Basic earnings per share for Q1 2023 were CNY 0.12, down from CNY 0.55 in Q1 2022[21]. Cash Flow and Liquidity - The net cash flow from operating activities increased significantly to ¥83,284,707.33, up 1,151.67% year-on-year[5]. - The company received increased export tax rebates, contributing to the rise in net cash flow from operating activities[6]. - The company's cash inflow from operating activities for Q1 2023 was not detailed in the provided documents[22]. - In Q1 2023, the cash inflow from operating activities totaled approximately $571.85 million, a decrease of 9.6% compared to $632.37 million in Q1 2022[24]. - The net cash flow from operating activities increased significantly to $83.28 million, compared to only $6.65 million in the same period last year, marking a substantial improvement[24]. - Cash outflow for purchasing goods and services was approximately $358.00 million, down 28.5% from $502.07 million in Q1 2022[24]. - The company reported a net cash outflow from investing activities of approximately -$136.75 million, an improvement from -$343.13 million in Q1 2022[25]. - Cash inflow from financing activities was approximately $48.37 million, a significant decrease from $1.01 billion in Q1 2022[25]. - The net cash flow from financing activities was $38.58 million, down from $945.90 million in the previous year[25]. - The ending cash and cash equivalents balance was approximately $1.70 billion, compared to $1.59 billion at the end of Q1 2022[25]. - The company received tax refunds amounting to approximately $30.36 million, an increase from $16.99 million in Q1 2022[24]. - The total cash outflow for operating activities was approximately $488.56 million, a decrease from $625.72 million in the same quarter last year[24]. - The company experienced a negative impact of approximately -$390,890 from exchange rate fluctuations on cash and cash equivalents[25]. Assets and Liabilities - Total assets at the end of the reporting period were ¥5,265,534,097.78, a decrease of 0.92% from the end of the previous year[5]. - The company's current assets totaled CNY 3,022,631,384.16, down from CNY 3,181,404,276.54, indicating a decrease of about 4.98% year-over-year[15]. - Cash and cash equivalents were reported at CNY 1,854,393,574.82, a decrease from CNY 1,924,266,642.91, representing a decline of approximately 3.63%[14]. - Accounts receivable decreased to CNY 275,807,562.61 from CNY 350,461,210.94, marking a reduction of about 21.34%[14]. - Inventory levels were reported at CNY 338,529,900.21, down from CNY 351,917,979.87, reflecting a decrease of approximately 3.79%[15]. - The company's long-term equity investments stood at CNY 219,625,070.97, slightly down from CNY 220,209,788.04, indicating a decrease of about 0.26%[15]. - Fixed assets decreased to CNY 839,153,644.10 from CNY 861,040,897.26, representing a decline of approximately 2.54%[15]. - The company's total liabilities decreased to CNY 1.91 billion in Q1 2023 from CNY 1.97 billion in Q1 2022, a reduction of 3.5%[17]. - The total equity increased to CNY 3.36 billion in Q1 2023 from CNY 3.34 billion in Q1 2022, reflecting a growth of 0.3%[17]. - The total current liabilities were not specified, but short-term borrowings decreased significantly from CNY 13,130,896.65 to CNY 4,935,784.06, a reduction of about 62.47%[15]. Market and Operational Insights - The decline in revenue was primarily due to decreased demand in the industry and a drop in both sales prices and quantities of major products[6]. - The company experienced a significant increase in sales expenses by 35.29% as it actively expanded into domestic and international markets[9]. - The report indicates that there are no significant new strategies or product developments mentioned for the upcoming quarters[14]. - The company plans to focus on market expansion and new product development in the upcoming quarters[22]. - Research and development expenses for Q1 2023 were CNY 31.37 million, slightly down from CNY 32.08 million in Q1 2022[19]. - The company reported an investment loss of CNY 277,693.54 in Q1 2023, compared to a gain of CNY 1.14 million in Q1 2022[20]. - The company reported a total of 72,000,000 shares held by its largest shareholder, accounting for 40% of the total shares[12].

Financial Performance - The company's operating revenue for 2022 was CNY 3,150,170,752.32, representing a 34.16% increase compared to CNY 2,347,993,708.64 in 2021[22]. - The net profit attributable to shareholders for 2022 was CNY 315,311,882.85, a 30.60% increase from CNY 241,432,485.47 in 2021[22]. - The net profit after deducting non-recurring gains and losses was CNY 311,642,772.14, reflecting a 29.45% increase from CNY 240,739,183.90 in 2021[22]. - The cash flow from operating activities for 2022 was CNY 519,443,185.81, which is a significant increase of 79.93% compared to CNY 288,695,478.03 in 2021[22]. - Total assets at the end of 2022 reached CNY 5,314,462,822.42, marking a 37.16% increase from CNY 3,874,747,210.35 at the end of 2021[23]. - The net assets attributable to shareholders increased to CNY 2,616,497,212.89, an 18.52% rise from CNY 2,207,607,292.68 in 2021[22]. - Basic earnings per share increased by 30.60% to CNY 1.75 in 2022 compared to CNY 1.34 in 2021[24]. - Diluted earnings per share rose by 11.19% to CNY 1.49 in 2022 from CNY 1.34 in 2021[24]. - The weighted average return on equity increased by 1.41 percentage points to 12.78% in 2022, up from 11.37% in 2021[24]. Dividend and Shareholder Returns - The company plans to distribute a cash dividend of CNY 5.50 per 10 shares (including tax) for the 2022 fiscal year[6]. - The company's net profit attributable to ordinary shareholders for the reporting period was approximately 315.31 million RMB, with a dividend payout ratio of 31.40%[173]. - The company has established a three-year dividend return plan (2021-2023) to enhance transparency and sustainability in profit distribution[168]. - The company has implemented a cash dividend policy, stating that cash dividends should not be less than 20% of the distributable profits for the year[164]. - The company plans to prioritize cash dividends, with a minimum of 80% for mature stages without major capital expenditures[164]. Operational Efficiency and Growth - The company achieved a consolidated revenue of 3.15 billion CNY, representing a year-on-year growth of 34.16%, and a net profit attributable to shareholders of 315 million CNY, up 30.60% year-on-year, indicating double growth in both revenue and net profit[35]. - The cash flow from operating activities improved due to growth in sales and profits, reflecting the company's operational efficiency[53]. - The company reported a significant increase in research and development expenses, attributed to enhanced investment in R&D and increased personnel and material costs[53]. - The company has established long-term strategic partnerships with leading clients in the industry, ensuring stable demand for its products[44]. - The company is focused on expanding its agricultural product supply chain and enhancing its operational capabilities in the chemical industry[73]. Market and Product Development - The sales volume of the active ingredient pyraclostrobin significantly increased due to deeper cooperation with strategic customers and a gradual recovery in downstream demand[36]. - The company is exploring the production of different grades of brominated polystyrene to meet diverse market demands, which is expected to enhance profitability as production capacity is gradually released[36]. - The company is focusing on the development of key materials and additives for high-quality chemical fiber, including flame retardants and catalysts, in line with national industrial development plans[41]. - The company is actively developing new, environmentally friendly flame retardants to meet the growing demand in various industries, including the automotive sector[89]. - The company is positioned to benefit from the new opportunities arising from the 5G infrastructure, which requires flame retardant materials for high-frequency PCB circuit boards and optical fibers[85]. Environmental Compliance and Sustainability - The company invested approximately 90.28 million yuan in environmental protection during the reporting period[178]. - The company is committed to environmental compliance and has established a framework for monitoring and reporting emissions[182]. - The company has implemented measures to ensure that emissions of key pollutants such as ammonia nitrogen and total phosphorus remain within regulatory limits[182]. - The company has established a comprehensive waste management system for both hazardous and general solid waste[198]. - The company has implemented new strategies for environmental compliance, including maintaining discharge standards for various pollutants[185]. Corporate Governance - The company has implemented a robust corporate governance structure, ensuring compliance with legal requirements and protecting shareholder rights[133]. - The company emphasizes strict compliance with legal and regulatory requirements for information disclosure, ensuring timely and accurate communication with shareholders[135]. - The company has established specialized committees, including the audit committee and the strategic committee, with specific members assigned[151]. - The company has a diverse board of directors, with members holding various positions and responsibilities[137]. - The company maintains a commitment to transparency and equal opportunity for all shareholders[135]. Research and Development - Research and development expenses increased by 22.34% to CNY 138.23 million, reflecting the company's commitment to innovation[51]. - The company obtained a total of 10 invention patents and 14 utility model patents during the reporting period, reflecting its commitment to R&D innovation[91]. - The company continues to enhance its R&D capabilities through partnerships with leading research institutions, focusing on new product development in pesticides and flame retardants[91]. - The company has a strategic focus on technology innovation, rewarding teams and individuals for advancements in product development and process improvements[160]. - The company employed 293 R&D personnel, which represents 21.58% of the total workforce[64].

江苏苏利精细化工股份有限公司 2022 年第三季度报告 证券代码：603585 证券简称：苏利股份 转债代码：113640 转债简称：苏利转债 江苏苏利精细化工股份有限公司 2022 年第三季度报告 一、 主要财务数据 (一)主要会计数据和财务指标 | | | | | 单位：元 币种：人民币 | | --- | --- | --- | --- | --- | | 项目 | 本报告期 | 本报告期 比上年同 | | 年初至报告期 末比上年同期 | | | | 期增减变 | 年初至报告期末 | 增减变动幅度 | | | | 动幅度(%) | | (%) | | 营业收入 | 791,344,650.44 | 31.52 | 2,434,674,002.42 | 54.49 | | 归属于上市公司股东的 | 65,994,290.39 | 55.80 | 265,109,611.69 | 90.35 | | 净利润 | | | | | | 归属于上市公司股东的 扣除非经常性损益的净 | 65,872,886.68 | 64.25 | 262,322,701.49 | 96.58 | | 利润 | | | | | | ...

Financial Performance - The company's operating revenue for the first half of 2022 reached CNY 1,643,329,351.98, representing a 68.68% increase compared to CNY 974,211,271.52 in the same period last year[20]. - Net profit attributable to shareholders was CNY 199,115,321.30, up 105.44% from CNY 96,919,247.98 year-on-year[20]. - The net cash flow from operating activities was CNY 236,856,236.71, an increase of 104.69% compared to CNY 115,714,872.55 in the previous year[20]. - Basic earnings per share for the first half of 2022 were CNY 1.11, up 105.56% from CNY 0.54 in the same period last year[21]. - The diluted earnings per share increased to CNY 0.99, representing an 83.33% increase compared to CNY 0.54 in the previous year[21]. - The weighted average return on equity rose to 8.21%, an increase of 3.52 percentage points from 4.69% in the same period last year[22]. - The company achieved consolidated revenue of CNY 1.643 billion, a year-on-year increase of 68.68%[39]. - Net profit attributable to shareholders reached CNY 199 million, reflecting a year-on-year growth of 105.44%[39]. Assets and Liabilities - The total assets of the company at the end of the reporting period were CNY 5,076,387,587.26, reflecting a 31.11% increase from CNY 3,871,812,905.97 at the end of the previous year[20]. - The net assets attributable to shareholders increased to CNY 2,506,822,046.18, a rise of 13.72% from CNY 2,204,468,089.72 at the end of the previous year[20]. - Total current assets increased to CNY 3,443,825,621.08 from CNY 2,406,656,060.81, representing a growth of approximately 43%[136]. - Total non-current assets reached CNY 1,632,561,966.18, compared to CNY 1,477,917,375.70, indicating an increase of about 10%[137]. - Total liabilities rose to CNY 1,857,771,955.71 from CNY 1,172,165,455.38, showing an increase of approximately 58%[138]. - The company's total assets amounted to CNY 5,076,387,587.26, up from CNY 3,884,573,436.51, representing a growth of about 30%[138]. Research and Development - Research and development expenses increased by 28.70% to CNY 69.74 million, driven by new projects and personnel growth[42]. - The company aims to strengthen its R&D capabilities and enhance its product offerings in the pesticide and fine chemical sectors[29]. - The company is focusing on enhancing its core competitiveness and R&D capabilities in response to national technology reform policies[41]. Market and Product Development - The company has seen a growing demand for its pesticide products due to increasing agricultural production needs and regulatory support[26]. - The overall market for pesticides is expected to grow, supported by government policies and increasing agricultural demands[26]. - The company is focusing on the production of pesticide products, including key products like Bacillus thuringiensis and pyraclostrobin, as well as flame retardants such as decabromodiphenyl ether[30]. - The company is actively pursuing market expansion and technological innovation to maintain its competitive edge[29]. Environmental Compliance and Sustainability - The company holds a pollution discharge permit and is classified as a key pollutant discharging unit, with specific emissions data reported[71]. - The company has implemented measures to ensure compliance with the emission standards set by the relevant environmental regulations[73]. - The company is focused on sustainable practices and environmental responsibility in its operations[76]. - The company has taken measures to reduce carbon emissions, including recycling steam condensate and implementing insulation on steam and hot water pipes to reduce energy loss[97]. Financial Management and Investments - The company completed a capital increase of RMB 205.2 million for its subsidiary Su Li Ningxia, raising its registered capital from RMB 300 million to RMB 430 million, maintaining a 76% ownership stake[49]. - The company issued RMB 957.21 million of convertible bonds, with a net fundraising amount of RMB 943.62 million after deducting issuance costs[124]. - The total amount of guarantees provided by the company, including those to subsidiaries, is RMB 821,000,000, which accounts for 25.51% of the company's net assets[115]. - The company plans to use cash flows from operating activities to repay the principal and interest of the convertible bonds in the future[133]. Risk Management - The company faced risks related to safety and environmental protection, emphasizing the need for compliance with increasingly stringent regulations[59]. - The company is facing risks from raw material price fluctuations, which significantly impact production and sales costs[61]. - The company has implemented measures to manage foreign exchange risks, including strengthening foreign exchange fund management and engaging in hedging activities[61]. Corporate Governance - The company has committed to fulfilling its obligations regarding performance compensation measures, with potential legal liabilities for any breaches[104]. - The company has not reported any violations or penalties against its directors, supervisors, or senior management during the reporting period[106]. - The company is focused on maintaining fair and reasonable pricing in its transactions with related parties[106]. Subsidiary Performance - The company’s subsidiary Su Li Chemical reported a net profit of RMB 2.59 million on revenue of RMB 31.71 million[58]. - The company’s subsidiary Bai Li Chemical achieved a net profit of RMB 21.71 million with revenue of RMB 133.44 million[58].

Financial Performance - The company's revenue for Q1 2022 reached ¥794,738,969.86, representing a 91.17% increase compared to the same period last year[6] - Net profit attributable to shareholders was ¥98,194,238.52, a significant increase of 158.48% year-on-year, primarily due to improved gross margins on product sales[6] - Basic earnings per share (EPS) increased by 161.90% to ¥0.55, while diluted EPS rose by 142.86% to ¥0.51[6] - Total operating revenue for Q1 2022 reached ¥794,738,969.86, a significant increase of 91.1% compared to ¥415,724,936.72 in Q1 2021[22] - Operating profit for Q1 2022 was ¥147,908,042.61, up 156.5% from ¥57,750,349.83 in the same period last year[23] - Net profit for Q1 2022 was ¥125,282,113.72, representing a 183.5% increase from ¥44,254,018.32 in Q1 2021[24] - Earnings per share for Q1 2022 were ¥0.55, compared to ¥0.21 in Q1 2021, reflecting a substantial growth[24] - The company reported a gross profit margin of approximately 18.9% for Q1 2022, compared to 13.5% in Q1 2021[22] - The total operating costs for Q1 2022 were ¥645,023,095.69, which is an increase of 81.0% from ¥356,305,364.10 in Q1 2021[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥4,819,476,288.77, reflecting a 24.48% increase from the previous year[6] - The company's total current assets as of March 31, 2022, amount to ¥3,320,270,006.20, an increase from ¥2,406,656,060.81 at the end of 2021[18] - Total assets reached ¥4,819,476,288.77, up from ¥3,871,812,905.97 in the previous year[19] - Total liabilities decreased to ¥1,693,539,362.40 from ¥1,853,540,948.74, reflecting a reduction of 8.6%[19] - Total liabilities as of Q1 2022 amounted to ¥1,707,105,162.30, compared to ¥1,172,165,455.38 in Q1 2021, indicating a growth of 45.5%[23] - Total equity increased to ¥3,112,371,126.47 in Q1 2022 from ¥2,699,647,450.59 in Q1 2021, marking a rise of 15.3%[23] Cash Flow - The company reported a net cash flow from operating activities of ¥6,653,878.88, which is not applicable for year-on-year comparison[6] - Cash flow from operating activities for Q1 2022 was ¥6,653,878.88, a recovery from a negative cash flow of ¥84,746,621.86 in Q1 2021[27] - The net cash flow from investment activities was -343,127,430.89 CNY, compared to -98,556,670.72 CNY in the previous period, indicating a significant increase in cash outflow for investments[28] - The total cash inflow from financing activities amounted to 1,005,244,175.73 CNY, with a net cash flow of 945,900,072.85 CNY after outflows[28] - The cash and cash equivalents at the end of the period reached 1,586,113,955.49 CNY, up from 884,927,397.46 CNY in the previous period, reflecting a net increase of 608,701,006.95 CNY[28] - The company received 947,019,207.06 CNY from borrowings during the financing activities, contributing significantly to the cash inflow[28] - The cash outflow for investment activities totaled 358,077,745.38 CNY, which is a substantial increase compared to 129,435,736.72 CNY in the previous period[28] - The company reported an increase in cash received from minority shareholders' investments amounting to 58,224,968.67 CNY[28] - The impact of exchange rate changes on cash and cash equivalents was -725,513.89 CNY, indicating a slight negative effect[28] Shareholder Information - Total number of ordinary shareholders at the end of the reporting period is 14,632[14] - The largest shareholder, Miao Jinfeng, holds 72,000,000 shares, representing 40.0% of total shares[15] - The number of shares held by the top ten shareholders accounts for a substantial portion of the company's equity, with the top shareholder alone holding 40%[15] Research and Development - Research and development expenses grew by 33.71%, attributed to increased investment in R&D projects and personnel[11] - Research and development expenses for Q1 2022 totaled ¥32,078,309.23, an increase of 33.8% from ¥23,990,655.01 in Q1 2021[23] Future Outlook - The company plans to continue expanding its product offerings and market presence, leveraging the increased demand and pricing power in its key product segments[11] - The company has not disclosed any significant new product developments or market expansion strategies in the current report[16]

Financial Performance - In 2021, the company's operating income reached approximately CNY 2.29 billion, representing a year-on-year increase of 47.03% compared to CNY 1.56 billion in 2020[21]. - The net profit attributable to shareholders was approximately CNY 232.39 million, an increase of 32.99% from CNY 174.75 million in the previous year[21]. - The cash flow from operating activities amounted to CNY 316.00 million, reflecting an 86.92% increase compared to CNY 169.06 million in 2020[21]. - The total assets of the company at the end of 2021 were approximately CNY 3.87 billion, a 26.19% increase from CNY 3.07 billion at the end of 2020[21]. - The company's net assets attributable to shareholders increased by 8.68% to approximately CNY 2.20 billion from CNY 2.03 billion in 2020[21]. - Basic earnings per share for 2021 were CNY 1.29, up 32.99% from CNY 0.97 in 2020[23]. - The weighted average return on equity was 11.01%, an increase of 2.26 percentage points from 8.75% in the previous year[23]. - The company achieved a historic breakthrough in consolidated operating revenue, indicating a stable recovery in profitability[32]. - The company achieved a consolidated revenue of 2.292 billion yuan, a year-on-year increase of 47.03%, and a net profit attributable to shareholders of 232 million yuan, up 32.99%[33]. Operational Highlights - In Q1 2021, the company's operating revenue was approximately ¥415.72 million, which increased to ¥715.72 million by Q4 2021, representing a growth of 72%[25]. - The net profit attributable to shareholders was ¥37.99 million in Q1 2021, rising to ¥93.12 million in Q4 2021, marking an increase of 145%[25]. - The cash flow from operating activities showed a significant recovery, moving from a negative ¥84.75 million in Q1 2021 to a positive ¥128.12 million in Q4 2021[25]. - The company achieved a consolidated revenue of CNY 2.292 billion, representing a year-on-year growth of 47.03%[46]. - The net profit attributable to shareholders reached CNY 232 million, marking a year-on-year increase of 32.99%[46]. Product and Market Development - The sales prices of key products such as pyraclostrobin, decabromodiphenyl ether, and hydrobromic acid maintained a growth trend in the second half of 2021, significantly contributing to revenue growth[33]. - The production of pyraclostrobin was stable, and the new production line for decabromodiphenyl ether operated well, leading to an increase in product output and sales volume[34]. - The revenue of the wholly-owned subsidiary, Suli Pharmaceutical, continued to grow, increasing by 32.99% compared to the same period last year[33]. - The company has completed the construction of a 15,000-ton decabromodiphenyl ether production line, which is expected to enhance profitability as it stabilizes operations[34]. - A new 5,000-ton brominated polystyrene production line has been completed and is ready for normal production, contributing to product structure improvement and market expansion[34]. Research and Development - The company is actively investing in R&D to enhance core competitiveness, with plans to build a more specialized R&D team and increase collaboration with academic institutions[34]. - The company has invested in R&D for new formulations and production technologies, particularly in the pesticide sector, to increase production capacity[43]. - The company received 11 invention patents during the reporting period, enhancing its innovation capabilities[87]. - The company emphasizes the importance of independent innovation, noting that firms with strong innovation capabilities will have better development opportunities[113]. Environmental Compliance and Sustainability - The company is committed to safety and environmental management, having obtained ISO14001 and OHSAS18001 certifications to ensure compliance with increasing regulatory standards[121]. - The company is focused on enhancing its production capabilities and expanding its market presence in the chemical industry[171]. - The company is actively monitoring and managing its environmental impact to align with regulatory requirements and sustainability goals[171]. - The company has implemented energy-saving measures, including the use of energy-efficient motors and automatic control of cooling systems, to reduce electricity consumption[195]. - The company has established an environmental self-monitoring plan for 2021, covering wastewater, waste gas, noise, and soil, with periodic monitoring conducted by qualified third parties[190]. Governance and Management - The company has established a governance structure compliant with regulations, ensuring independent operation of the board and effective decision-making[127]. - The board consists of 9 members, including 3 independent directors, ensuring compliance with legal requirements and effective governance[128]. - The company has a diverse board with members having extensive experience in various sectors, enhancing its strategic decision-making capabilities[135]. - The company’s governance structure includes independent directors who contribute to oversight and compliance, ensuring transparency in operations[135]. - The total remuneration for all directors, supervisors, and senior management was 7.2456 million yuan[142]. Employee Development and Welfare - In 2021, the company organized 433 training programs, achieving a completion rate of over 99%, reflecting a commitment to employee development[155]. - The company emphasizes safety and skill enhancement, with nearly 150 employees participating in safety training and skill improvement programs in 2021[154]. - The company has committed to protecting employee rights and has improved employee welfare, including timely payment of social insurance[196]. - The company has a diverse educational background among employees, with 5 holding PhDs and 28 holding master's degrees, enhancing its technical expertise[153]. Risk Management - The company faced challenges due to global supply chain shortages and inflationary pressures, which may impact future operations and profitability[31]. - The company is preparing for potential risks related to safety, environmental compliance, and supply chain disruptions due to ongoing pandemic-related challenges[122]. - The company is exposed to foreign exchange risks due to high overseas procurement and sales, with measures in place to manage currency fluctuations and mitigate financial risks[123]. - Ongoing capital investments in projects like the Ningxia project may lead to financial pressure and uncertain returns, prompting the company to improve investment management and efficiency[124].

Financial Performance - The company's operating revenue for Q3 2021 was CNY 601,713,613.19, representing a year-on-year increase of 35.30%[4] - The net profit attributable to shareholders for Q3 2021 was CNY 42,358,559.22, a decrease of 3.40% compared to the same period last year[4] - The net profit after deducting non-recurring gains and losses for Q3 2021 was CNY 40,105,030.16, down by 8.08% year-on-year[4] - Total operating revenue for the first three quarters of 2021 reached RMB 1,575,924,884.71, a significant increase of 42% compared to RMB 1,111,140,145.23 in the same period of 2020[18] - The company reported a net profit margin improvement, with net profit for the first three quarters of 2021 expected to be higher than in the same period of 2020, although specific figures were not disclosed[18] - In Q3 2021, the company's net profit was CNY 165,938,727.86, slightly down from CNY 166,157,482.49 in Q3 2020, representing a decrease of 0.13%[19] - The operating profit for Q3 2021 was CNY 205,823,269.65, an increase of 4.0% compared to CNY 197,251,570.45 in the same period last year[19] - Basic and diluted earnings per share for Q3 2021 were both CNY 0.77, an increase from CNY 0.72 in Q3 2020[20] - The company’s total comprehensive income for Q3 2021 was CNY 165,840,518.73, slightly down from CNY 166,157,482.49 in Q3 2020[20] Assets and Liabilities - The total assets at the end of Q3 2021 amounted to CNY 3,514,310,412.04, reflecting a growth of 14.54% compared to the end of the previous year[5] - As of September 30, 2021, total assets were RMB 3,514,310,412.04, an increase from RMB 3,068,246,382.92 at the end of 2020[16] - Current assets totaled RMB 2,131,105,836.25, compared to RMB 1,820,541,395.14 at the end of 2020, reflecting a growth of 17%[14] - The company's total liabilities reached RMB 894,030,770.40, compared to RMB 547,970,522.78 at the end of 2020, representing a rise of 63%[17] - The company's total liabilities increased to CNY 1,066,649,277.12 as of the end of Q3 2021, compared to CNY 1,231,846,840.72 at the end of Q3 2020[23] - Shareholders' equity stood at CNY 2.520 billion, reflecting a stable financial position[28] Cash Flow - The net cash flow from operating activities for the year-to-date period was CNY 187,884,084.63, an increase of 55.71% year-on-year[4] - The net cash flow from operating activities for the first three quarters of 2021 was CNY 187,884,084.63, compared to CNY 120,659,686.55 in the same period of 2020, reflecting a growth of 55.6%[23] - The company reported a net cash outflow from investing activities of CNY 280,603,231.11 in the first three quarters of 2021, worsening from a net outflow of CNY 231,137,956.74 in the same period of 2020[23] - The company's cash and cash equivalents decreased to RMB 999,534,810.60 from RMB 1,082,548,233.21 at the end of 2020, a decline of approximately 7.7%[14] - The cash and cash equivalents at the end of Q3 2021 were CNY 920,751,652.80, down from CNY 1,006,117,961.80 at the end of Q3 2020[23] - The company’s cash and cash equivalents were CNY 1.083 billion, ensuring liquidity for operations[26] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,887[10] - The top ten shareholders held a combined 40% of the shares, with the largest shareholder owning 72,000,000 shares[10] Research and Development - Research and development expenses rose to CNY 84,382,778.59 in Q3 2021, up from CNY 60,652,667.96 in Q3 2020, marking an increase of 39.0%[19] Inventory and Management - Inventory as of September 30, 2021, was RMB 233,949,402.20, up from RMB 220,692,058.37, indicating an increase of approximately 6%[14] - The company has a total of CNY 220.69 million in inventory, indicating a solid inventory management strategy[26] Other Financial Metrics - The weighted average return on equity for Q3 2021 was 2.02%, a decrease of 0.21 percentage points from the previous year[5] - The company is undergoing a re-certification process for its subsidiary's high-tech enterprise qualification, which may impact net profit due to tax rate adjustments[5] - The company has recognized a deferred tax asset of CNY 5.01 million, which may benefit future tax liabilities[27] - The company’s goodwill and intangible assets were valued at CNY 132.81 million, reflecting its investment in brand and technology[27] - The company has implemented new accounting policies effective January 1, 2021, impacting financial reporting[29]